Navigation Links
Shire plc: Strong Third Quarter and Increased Non GAAP Earnings Expectations
Date:10/24/2013

ation payments (2.5) (3.0) (11.3) (3.0) Other, net 1.7 (0.3) (5.5) (2.6) Net cash used in financing activities(C) (10.2) (40.0) (327.3) (88.6) Effect of foreign exchange rate changes on cash and cash equivalents (D) 2.4 (3.5) (0.5) (5.1) Net increase in cash and cash equivalents(A) +(B) +(C) +(D) 384.2 209.2 203.9 701.9 Cash and cash equivalents at beginning of period 1,301.9 1,112.7 1,482.2 620.0 Cash and cash equivalents at end of period 1,686.1 1,321.9 1,686.1 1,321.9

Unaudited US GAAP results for the three months and nine months to September 30, 2013

Selected Notes to the Financial Statements

 (1)  Earnings Per Share ("EPS")

9 months 9 months 3 months to 3 months to to to September September September 30, September 30, 30, 30, 2013 2012 2013 2012 $M $M $M $M Numerator for basic EPS 278.2 227.2 601.1 703.4 Interest on convertible bonds, net of tax 7.6 7.5 22.7 23.7 Numerator for diluted EPS 285.8 234.7 623.8 727.1 Weighted average number of shares: Millions Millions Millions Millions Basic(1) 548.4 555.9 549.8 555.5 Effect of dilutive shares: Share based awards to employees(2) 3.5 3.7 3.9 5.0 Convertible bonds 2.75% due 2014(3) 33.8 33.5 33.8 33.5 Diluted 585.7 593.1 587.5 594.0

  1. Excludes shares purchased by the EBT and under the share buy-back program and presented by Shire as treasury stock.
  2. Calculated using the treasury stock method.
  3. Calculated using the "if converted" method.

The share equivalents not included in the calculation of the diluted weighted average number of shares are shown below:

9 months 9 months 3 months to 3 months to to to September September September 30, September 30, 30, 30, 2013 2012 2013 2012 Millions Millions Millions Millions Share based awards to employees(1) 0.5 6.6 4.5 4.9

  1. Certain stock options have been excluded from the calculation of diluted EPS because (a) t
    '/>"/>

SOURCE Shire plc
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29

Related biology technology :

1. Shire to Acquire FerroKin BioSciences, Inc., and its Phase 2 Iron Chelator Treatment
2. Heptares Grants Shire an Exclusive Worldwide Licence to Develop and Commercialise Novel Drug Candidate for CNS Disorders
3. Shire plc: First Quarter 2012 Results Date Notification - April 26, 2012
4. Shire Facebook Page Increases Awareness of Hereditary Angioedema (HAE) in Support of First HAE Awareness Day May 16th
5. Berkshire Corporation Offers Live Chat For Americas Website and Shopping Cart
6. Shire Changes its NASDAQ Ticker Symbol to SHPG
7. Dr. Jeff Jonas Appointed President of Shire Regenerative Medicine Business and Joins Shire Leadership Team
8. Shire and Boston Childrens Hospital Enter Into Broad Research Collaboration
9. Shire Reaches Agreement in Principle With U.S. Government
10. Shire Regenerative Medicine Initiates Phase 3 Study of ABH001 for Patients with Epidermolysis Bullosa
11. Shire to Acquire SARcode Bioscience, Expands Presence in Ophthalmology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... ... ... VetStem Biopharma will be offering weekly private guided tours of our new ... The tour and course will be given every Wednesday at 6pm to local interested ... members are welcome to attend with their veterinarian as well. Participants will be able ...
(Date:7/28/2015)... N.J. , July 28, 2015  Moerae ... second Phase 1 clinical trial with MMI-0100, a ... is being developed for pulmonary disorders characterized by ... United Kingdom , is a ... further evaluating the safety and tolerability of MMI-0100 ...
(Date:7/28/2015)... and RESEARCH TRIANGLE PARK, N.C., July 28, 2015 /PRNewswire/ ... announced its financial results for the second quarter ... grew nearly 300% as compared to the second ... launched," said Roger Jeffs, Ph.D., United Therapeutics, President ... sales was due to an increase in the ...
(Date:7/27/2015)... and FRANKLIN, Tenn. ... a privately-owned  premier provider of health care services ... in the U.S., today announced that its parent ... signed a definitive agreement with Medical Properties Trust, ... acquisition of Capella for $900 million in cash.  The transaction ...
Breaking Biology Technology:VetStem Biopharma weekly veterinary continuing education classes and GMP manufacturing facility tour 2Moerae Initiates Lipopolysaccharide (LPS) Challenge Study of Inhaled MMI-0100 for Pulmonary Disease Following Encouraging Safety and Tolerability Observed in Single Ascending Dose Phase 1 Study 2United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 2United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 3United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 4United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 5United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 6United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 7United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 8United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 9United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 10United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 11Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 2Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 3Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 4Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 5
... May 1 Orchid Cellmark Inc.,(Nasdaq: ORCH ), ... release its first quarter 2008 financial results on,Thursday, May ... hosting a,conference call and webcast to discuss the results ... discuss financial results for the first quarter,2008 as well ...
... April 30 BioMed Realty Trust, Inc.,(NYSE: BMR ... lease for more,than 140,000 square feet at the Pacific ... Inc.,(Nasdaq: DSTI ) will join BioMed,s rapidly expanding ... East Bay of San Francisco,s thriving,technology corridor., DayStar ...
... DIEGO, April 30 Gen-Probe Incorporated,(Nasdaq: GPRO ) ... Bank 33rd Annual Health Care Conference on May 6 ... to be webcast live,and may be accessed through a ... http://www.gen-probe.com . The webcast will be available for 30,days ...
Cached Biology Technology:Orchid Cellmark to Announce First Quarter 2008 Financial Results on May 8, 2008 2BioMed Realty Trust Announces 140,000 Square Foot Lease With DayStar Technologies at Pacific Research Center 2BioMed Realty Trust Announces 140,000 Square Foot Lease With DayStar Technologies at Pacific Research Center 3Gen-Probe to Webcast Presentation at Deutsche Bank 33rd Annual Health Care Conference 2
(Date:7/21/2015)... , July 21, 2015 Today, ZTE announced ... received as well as expected revenues in 2015 that relate to ... communicated revenue guidance of approximately 2,200 MSEK for 2015. ... a leading smartphone manufacturer in China and ... 02 5 for Axon , ...
(Date:7/13/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... focused on the growing mobile commerce market, announced ... for BEHAVIORAL-DIRECTED AUTHENTIATION METHOD AND SYSTEM. ... secure method to make payments.  With this patent, ... with its groundbreaking voice-direct payment patent application, with ...
(Date:7/8/2015)... 2015 Summary Pancreatic cancer is the ... fatal, with a mortality rate of 10.9 deaths per ... cancer patients has highlighted a significant need for new ... met by the current market. A highly active ... varying molecule types and mechanisms of action, which provides ...
Breaking Biology News(10 mins):FPC's Touch Fingerprint Sensor FPC1025 in ZTE's Smartphone Axon 2NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3
... bond is reflected by the similarity of their scents, finds ... but with smells instead of sounds," said Christine Drea, a ... researchers sampled and analyzed scent secretions produced by lemurs known ... Durham, NC. The researchers also monitored the animals, scent-marking and ...
... known for its role in digestion. But this collection of organs ... it is one of the first parts of the body that ... how the virus infects cells and accumulates in this area is ... worldwide living with HIV. Researchers at the California Institute of Technology ...
... allow yourself to be exposed to smoke because second-hand smoke ... says a scientist at the University of California, Riverside who, ... effects of third-hand smoke. While first-hand smoke refers to ... the exhaled smoke and other substances emanating from the burning ...
Cached Biology News:Lemur lovers sync their scents 2Lemur lovers sync their scents 3A detailed look at HIV in action 2A detailed look at HIV in action 3Third-hand smoke shown to cause health problems 2Third-hand smoke shown to cause health problems 3Third-hand smoke shown to cause health problems 4
... mouth PYREX Fernbach-style culture flask is designed for ... volume ratio. It can also be used in ... edges to achieve maximal oxygen transfer to culture ... and accepts cotton plugs or No. 13 rubber ...
... 30 isolations. The kit provides a ... apoptotic cells from normal c lture using ... is a Ca2+-dependent phospholipid binding protein with ... Cell Isolation Kit provides a simple and ...
... 5mm diameter, 7 inch long PYREX NMR tubes ... with ground joints, valves, and vacuum racks. They ... from 300 to 500MHz. They have an O.D. ... 4.20 + 0.013-0.000mm. These NMR tubes can be ...
Standard Fluka For microscopy (Hist.) redox indicator...
Biology Products: